NL-OMON42320
Recruiting
Not Applicable
Treatment of chronic hepatitis C infection with direct acting antivirals: effects on liver fibrosis and patient reported outcomes - DURACE study
Afdeling Maag-, Darm en Leverziekten0 sites100 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Hepatitis C infection
- Sponsor
- Afdeling Maag-, Darm en Leverziekten
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- Chronic hepatitis C
- •\- Age \> 18 years
- •\- METAVIR score F3\-F4 (classified by liver biopsy or Fibroscan score \>9,5 kPa)
- •\- Status after liver transplantation or on the waiting list for liver transplantation
- •\- Severe extra hepatic disease (HCV\-related skin disease like prophyria cutanea tarda or leukocytoclastic vasculitis; or HCV related renal impairment secondary to cryoglobulinemia
Exclusion Criteria
- •\- Patients who don't meet the criteria for DAA treatment
- •\- Patients who are not able to visit the outpatient clinic at regular basis
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Evaluation of chronic hepatitis C treatment with PEG-IFN ALFA-2a and ribavirin in HIV-positive subjects with persistently normal transaminase levels. - Treatment of co-infected patients with normal ALTTreatment of adult patients with hystologically demonstrated chronic C hepatitis without hepatic failure and HCV-RNA positive, treatment of patients with normal ALT and with HIV/HCV co-infection.MedDRA version: 9.1Level: LLTClassification code 10019744Term: Hepatitis CEUCTR2007-005698-76-ITAZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE)
Active, not recruiting
Phase 1
Direct acting antiviral therapy of hepatitis C in Denmark: treatment response, adverse events and resistance associated variantsPatients with chronic hepatitis CMedDRA version: 19.1Level: LLTClassification code 10074391Term: Chronic hepatitis C virus genotype 1System Organ Class: 100000004862Therapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2015-001956-31-DKDepartment of Infectious Diseases, Copenhagen University Hospital, Hvidovre.111
Completed
Not Applicable
Retreatment of hepatitis C non-responsive to Interferon: a placebo controlled randomised trial of Ribavirin monotherapy versus combination therapy with Ribavirin and Interferon in 121 patients in the BeneluxChronic hepatitis CInfections and InfestationsHepatitisISRCTN53821378Schering Plough International (USA)117
Completed
Phase 2
A pilot phase II open-label study of oglufanide disodium in patients with chronic hepatitis CChronic hepatitis CInfection - Other infectious diseasesACTRN12607000418471Implicit Bioscience Pty Ltd17
Completed
Not Applicable
TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C (HCC) USING PEG-INTERFERON ALPHA 2B AND RIBAVIRINEPER-039-01SCHERING PLOUGH RESEARCH INSTITUTE,